Cathie Wood's ARK ETFs have made their daily trades public for Thursday, January 23rd, 2025, displaying a strategic shift in their portfolio holdings. The trades indicate a continued interest in biotech with a notable sell-off in the healthcare services sector.

Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.

Cathie Wood, chief executive of Ark Investment Management, frequently buys technology stocks that she says will disrupt a number of sectors. Sometimes, her strategy pays off: The flagship Ark Innovation ETF ( ARKK) has gained 5% this year as of Jan. 17, outperforming the S&P 500 and the Nasdaq Composite.

Curating today’s top interviews from around Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Investing guru Cathie Wood remains an investor favorite. Although the founder of the ARK Invest family of exchange-traded funds (ETFs) lost to the market in 2024, it was not an even performance.  Where her flagship ARK Innovation ETF (NYSEARCA:ARKK) only gained 12% last year versus the 24% rise by the S&P 500,

Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs. There are other ETFs with similar specialties. In other words,

Wood's latest move was to decrease her position in a stock that was the S&P 500 's top performer last year. The famous investor sold shares of this technology player during several recent trading sessions. Should you follow her and stay away from this player in 2025?